Navigation Links
Jean-Pol Tassin wins the 2009 ECNP Neuropsychopharmacological Award
Date:9/23/2009

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Jean-Pol Tassin as the recipient of the 2009 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering and innovative research into the neurochemical basis of substance addiction.

The ECNP Neuropsychopharmacology Award recognises outstanding research in the field of neuropsychopharmacology and its closely related disciplines. Granted annually, the award alternates between basic science and clinical research and is accompanied by a prize of EUR 20,000. Jean-Pol Tassin Tassin is the award's 31st recipient.

Jean-Pol Tassin, currently team leader at the Collge de France's Molecular Genetic, Neurophysiology and Behaviour Laboratory in Paris, was drawn to addiction by his early research on nerve terminals in the prefrontal cortex and the effects of stress and long-term isolation on the meso-cortical pathway. Moving to studies on the impact of psychostimulants on cortical and sub-cortical neurons, his critical insight was to connect the disruption of nonadrenaline and serotonin neuron interaction with addictive behaviour. Jean-Pol Tassin's research showed how these neurons, when exposed to repeated psychostimulant abuse, become 'uncoupled,' thereby inducing distress, or withdrawal, for which further administrations of the drug are needed to achieve relief. Later refinements to this groundbreaking model have highlighted the key role played in tobacco addiction by monoamine inhibitors present in cigarettes.

Presenting the award at the 22nd ECNP Congress in Istanbul, the chairman of the ECNP Award Jury 2009, Tomas Hkfelt of the Karolinska Institute in Stockholm, commended Tassin's scientific originality as well as his landmark contribution to our understanding of this critical public health concern.


'/>"/>

Contact: Sonja Mak
s.mak@update.europe.at
431-405-5734
European College of Neuropsychopharmacology
Source:Eurekalert

Page: 1

Related biology news :

1. ESF EURYI award winner aims to stop cancer cells reading their own DNA
2. The American Society of Plant Biologists announces 2007 awards
3. Minimally invasive heart surgery research wins NIH award
4. 12 McGill researchers awarded Canada Research Chairs
5. Herr receives Heinz Award for Technology, the Economy and Employment
6. Singapore National Science and Technology Awards
7. RSC Project Prospect scoops prestigious award
8. Springer book wins Quality of Communication Award
9. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
10. NIH awards nearly $23M to University of Chicago for translational research
11. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... changing into a different cell type. Many treatments for specific cancers, such as ... example of targeted treatment is androgen deprivation therapy for advanced prostate cancer. ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar Biologics ... secured $2M in funding from an impressive group of investors, including Rev1 Ventures, ... Fund. With this investment, 3Bar is broadening availability of its groundbreaking offering that ...
(Date:8/16/2017)... 16, 2017  This year,s edition of the Inc. 5000 features a ... workforce solutions, has made the list for the third year in a ... fastest-growing private companies based on a set of quantitative metrics. In addition, ... fastest-growing companies in the Bay State . ... Inc. 5000 ...
(Date:8/15/2017)... , Aug. 15, 2017 After spending the past two ... with crowdsourced data collection, GeneFo now offers this platform to healthcare ... and amplifying support, adherence, and data collection vis a vis their ... mark the successful launch of this offer. ... GeneFo ...
Breaking Biology Technology: